GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (XTAE:BOLT) » Definitions » Retained Earnings

BioLight Life Sciences (XTAE:BOLT) Retained Earnings : ₪-249.97 Mil (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is BioLight Life Sciences Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. BioLight Life Sciences's retained earnings for the quarter that ended in Dec. 2024 was ₪-249.97 Mil.

BioLight Life Sciences's quarterly retained earnings increased from Dec. 2023 (₪-242.82 Mil) to Jun. 2024 (₪-241.99 Mil) but then declined from Jun. 2024 (₪-241.99 Mil) to Dec. 2024 (₪-249.97 Mil).

BioLight Life Sciences's annual retained earnings declined from Dec. 2022 (₪-216.80 Mil) to Dec. 2023 (₪-242.82 Mil) and declined from Dec. 2023 (₪-242.82 Mil) to Dec. 2024 (₪-249.97 Mil).


BioLight Life Sciences Retained Earnings Historical Data

The historical data trend for BioLight Life Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Retained Earnings Chart

BioLight Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -209.34 -208.96 -216.80 -242.82 -249.97

BioLight Life Sciences Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -216.80 - -242.82 -241.99 -249.97

BioLight Life Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


BioLight Life Sciences  (XTAE:BOLT) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


BioLight Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
Aba Hillel Silver 12, 11 floor, Ramat Gan, ISR, 5250606
BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.

BioLight Life Sciences Headlines

From GuruFocus